Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-11

Clinical Trial Update: Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis [Phase 1]

View source ↗

Summary

Open-label Phase 1 study evaluating RVT-501 topical ointment in pediatric patients with atopic dermatitis; the document provides trial details but does not repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RVT-501 topical ointment (RVT-501)

Snippet

Sponsor: Dermavant Sciences GmbH | Conditions: Atopic Dermatitis | Phase 1 | Status: UNKNOWN